Novartis Faces Trial Or Settlement After Judge Rules in Favor of Whistleblower Suit

Drug Industry Daily
Novartis finds itself in a tough spot after a federal judge refused the company’s request to toss a whistleblower lawsuit that could cost the Swiss-based pharma giant hundreds of millions of dollars.

To View This Article:


Subscribe To Drug Industry Daily